References:
  1. Perricone, C., Ceccarelli, F., Nesher, G. et al. Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases. Immunol Res 60, 226–235 (2014)
  2. Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009; 113:2386.
  3. Rinaldi M, Perricone C, Ortega-Hernandez OD, Perricone R, Shoenfeld Y. Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines. Lupus. 2014;23:554–67.
  4. Lee EJ, Cines DB, Gernsheimer T, Kessler C, Michel M, Tarantino MD, Semple JW, Arnold DM, Godeau B, Lambert MP, Bussel JB. Thrombocytopenia following Pfizer and Moderna SARS‐CoV‐2 vaccination. American Journal of Hematology. 2021 Feb 19.
  5. Sanne E. de Jong, Axel Olin, Bali Pulendran, The Impact of the Microbiome on Immunity to Vaccination in Humans. Cell Host & Microbe. Volume 28, Issue 2 2020 ISSN 1931-3128.
  6. Cuker A, Prak ET, Cines DB. Can immune thrombocytopenia be cured with medical therapy? Semin Thromb Hemost 2015; 41:395.
  7. Gudbrandsdottir, S., Leven, E., Imahiyerobo, A., Lee, C.S. and Bussel, J. (2020), Combination of thrombopoietin receptor agonists, immunosuppressants and intravenous immunoglobulin as treatment of severe refractory immune thrombocytopenia in adults and children. Br J Haematol, 189: e37-e40.
  8. Charlotte A Bradbury, Rosemary Greenwood,Julie Pell, Katie Breheny,Rebecca Kandiyali,Jenny Ingram,Ian Thomas,Catherine Bagot, Quentin Hill,Nichola Cooper. A multicentre randomised trial of first line treatment pathways for newly diagnosed immune thrombocytopenia: Standard steroid treatment versus combined steroid and mycophenolate. the Flight Trial.Blood  (2020) 136 (Supplement_2): LBA-2.
  9. Walsh EE, Frenck RW Jr, Falsey AR, et al. Safety and immunogenicity of two RNA‐based Covid‐19 vaccine candidates. N Engl J Med. 2020; 383(25): 2439‐ 2450.